Jazz Pharmaceuticals plc — Director's Dealing 2012

Jun 4, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2012-05-31

Reporting Person: COZADD BRUCE C (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-31	Ordinary Shares	J	596	$25.13	Acquired	497662	Direct

Footnotes

F1: Shares acquired through a qualified Section 423 Employee Stock Purchase Plan.